These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37877218)

  • 1. Leveraging QM/MM and Molecular Dynamics Simulations to Decipher the Reaction Mechanism of the Cas9 HNH Domain to Investigate Off-Target Effects.
    Maghsoud Y; Jayasinghe-Arachchige VM; Kumari P; Cisneros GA; Liu J
    J Chem Inf Model; 2023 Nov; 63(21):6834-6850. PubMed ID: 37877218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into DNA cleavage activation of CRISPR-Cas9 system.
    Huai C; Li G; Yao R; Zhang Y; Cao M; Kong L; Jia C; Yuan H; Chen H; Lu D; Huang Q
    Nat Commun; 2017 Nov; 8(1):1375. PubMed ID: 29123204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Reduced Dynamics of Three Engineered HNH Endonuclease Lys-to-Ala Mutants for the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Associated 9 (CRISPR/Cas9) Enzyme.
    Wang J; Skeens E; Arantes PR; Maschietto F; Allen B; Kyro GW; Lisi GP; Palermo G; Batista VS
    Biochemistry; 2022 May; 61(9):785-794. PubMed ID: 35420793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
    Zheng W
    Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional insights into the
    Zuo Z; Zolekar A; Babu K; Lin VJ; Hayatshahi HS; Rajan R; Wang YC; Liu J
    Elife; 2019 Jul; 8():. PubMed ID: 31361218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and dynamic insights into the HNH nuclease of divergent Cas9 species.
    Belato HB; D'Ordine AM; Nierzwicki L; Arantes PR; Jogl G; Palermo G; Lisi GP
    J Struct Biol; 2022 Mar; 214(1):107814. PubMed ID: 34871741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of Neisseria meningitidis Cas9 Complexes in Catalytically Poised and Anti-CRISPR-Inhibited States.
    Sun W; Yang J; Cheng Z; Amrani N; Liu C; Wang K; Ibraheim R; Edraki A; Huang X; Wang M; Wang J; Liu L; Sheng G; Yang Y; Lou J; Sontheimer EJ; Wang Y
    Mol Cell; 2019 Dec; 76(6):938-952.e5. PubMed ID: 31668930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
    Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
    Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time observation of flexible domain movements in CRISPR-Cas9.
    Osuka S; Isomura K; Kajimoto S; Komori T; Nishimasu H; Shima T; Nureki O; Uemura S
    EMBO J; 2018 May; 37(10):. PubMed ID: 29650679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational control of DNA target cleavage by CRISPR-Cas9.
    Sternberg SH; LaFrance B; Kaplan M; Doudna JA
    Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key role of the REC lobe during CRISPR-Cas9 activation by 'sensing', 'regulating', and 'locking' the catalytic HNH domain.
    Palermo G; Chen JS; Ricci CG; Rivalta I; Jinek M; Batista VS; Doudna JA; McCammon JA
    Q Rev Biophys; 2018; 51():. PubMed ID: 30555184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time observation of Cas9 postcatalytic domain motions.
    Wang Y; Mallon J; Wang H; Singh D; Hyun Jo M; Hua B; Bailey S; Ha T
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33443184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9-catalyzed DNA Cleavage Generates Staggered Ends: Evidence from Molecular Dynamics Simulations.
    Zuo Z; Liu J
    Sci Rep; 2016 Nov; 5():37584. PubMed ID: 27874072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
    Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
    Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Insights Revealed by the Kinetic Mechanism of CRISPR/Cas9.
    Raper AT; Stephenson AA; Suo Z
    J Am Chem Soc; 2018 Feb; 140(8):2971-2984. PubMed ID: 29442507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9.
    Zhu X; Clarke R; Puppala AK; Chittori S; Merk A; Merrill BJ; Simonović M; Subramaniam S
    Nat Struct Mol Biol; 2019 Aug; 26(8):679-685. PubMed ID: 31285607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 Structures and Mechanisms.
    Jiang F; Doudna JA
    Annu Rev Biophys; 2017 May; 46():505-529. PubMed ID: 28375731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.